![]() |
|
|
2 UMR 1019-Unité de Nutrition Humaine, Institute National de la Recherche Agronomique, Centre de Recherche de Clermont-Ferrand/Theix, F-63122 St-Genès-Champanelle, France and 3 UMR 1089-Xénobiotiques, Institute National de la Recherche Agronomique-Ecole National Vétérinaire de Toulouse, BP 3, 31931 Toulouse Cedex 9, France
* To whom correspondence should be addressed. E-mail: afardet{at}clermont.inra.fr.
| ABSTRACT |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Exactly how whole-grain cereals protect against metabolic diseases remains largely unknown, partly because of the diversity of the active constituents in whole-grain products and partly because of the complexity of the metabolic responses to each of them.
1H NMR spectroscopy or MS can be used in a metabonomic study to analyze simultaneously several hundreds or thousands of metabolites in biological fluids such as urine, plasma, or tissues (8). Multivariate statistical analysis is then used to identify markers influenced by an intervention (9). This approach is capable of describing the effects of diet on metabolism, because it can assay many metabolites in a single sample; traditional approaches focused on specific biomarkers often fail to detect metabolic changes. Metabonomic studies on the influence of complex foods or diets on metabolic profiles have been used only rarely to date. The regular consumption of chamomile tea was shown to influence urinary metabolic profiles in humans (10). These effects were persistent and still observed 14 d after ending chamomile consumption, possibly because of some modifications of the gut microbiota. Ingesting soy isoflavone affects human endogenous metabolism, including osmolyte fluctuation and energy metabolism (11). A metabolomic study also revealed some effects of epicatechin consumption on the endogenous metabolism of rats (12).
We have postulated that there are detectable, unequivocal differences in the metabolism of animals consuming whole-grain cereals and those consuming refined grain. We fed rats diets containing 60% whole-grain wheat flour (WGF)4 or refined wheat flour (RF) and monitored their general metabolism using a 1H-NMR-based metabonomic approach and more conventional metabolic biomarkers of fiber fermentation, lipid status, and oxidative stress. The changes in some of these markers suggest that whole-grain cereals have previously unrecognized metabolic effects that may explain their health benefits.
| Materials and Methods |
|---|
|
|
|---|
Sampling procedures.
Rats were anaesthetized at the end of the dark period with sodium pentobarbital (40 mg/kg) and maintained at 37°C during sample collection. An abdominal incision was made and blood was withdrawn from the abdominal aorta into heparinized tubes. It was centrifuged at 12,000 x g for 2 min and the supernatant (plasma) was collected and stored at –80°C for lipid analysis (triglycerides and cholesterol), antioxidant capacity [ferric-reducing ability of plasma (FRAP) and malondialdehydes (MDA)], antioxidant quantification (vitamins E and C) and 1H NMR analyses. The cecum (wall with contents) was then removed and weighed. Cecal contents were collected into 2-mL microfuge tubes, frozen, and stored at –20°C for assays of SCFA. The liver was weighed and freeze-clamped into liquid nitrogen and stored at –80°C for the measurement of triglycerides, cholesterol, and betaine concentrations, and 1H NMR analyses. The urine collected twice per day (see above) was stored at –20°C for analysis of MDA and isoprostane [8-epi-prostaglandin F2
(8-epi-PGF2
)] concentrations and 1H NMR analyses.
Analytical procedures.
SCFA concentrations were measured by GLC on the supernatants (8000 x g; 5 min at 4°C) of cecal contents (18). Plasma triglycerides and total cholesterol were determined enzymatically using kits purchased from BioMérieux (Triglycerides PAP 150 and Cholesterol RTU). Liver triglycerides and cholesterol were extracted and analyzed as described by Mazur et al. (14). The FRAP was determined as described previously (15). The TBARS in plasma and urine samples were measured by the modified procedure of Lee et al. (16) by reading absorbance at 532 nm. TBARS were measured in urine collected during the PP period (from 1600 to 0900, i.e. 17 h) on d 27 and expressed as nmol equivalents of MDA excreted during 17 h. Plasma vitamin E (
-tocopherol) was analyzed by HPLC-UV according to Lyan et al. (17). Plasma ascorbic acid was determined according to Tessier et al. (18). Isoprostane (8-epi-PGF2
) in urine collected during the PP period was determined with a commercial kit (Oxford Biomedical Research). 8-epi-PGF2
was measured on d 27 and expressed in ng of 8-epi-PGF2
excreted in 17 h.
Sample preparation for 1H NMR spectroscopy.
Urine samples were prepared for NMR spectroscopy by mixing 500 µL urine with 200 µL phosphate buffer in D2O (pH 7.4) containing 10 mmol/L deuterated trimethylsilylpropionate as chemical shift reference (
0.0 ppm). The buffered urine samples were then centrifuged at 4600 x g for 10 min to remove any precipitates and aliquots of the resulting supernatant (600 µL) were placed in 5-mm NMR tubes. Plasma samples were prepared for NMR spectroscopy by mixing 400 µL plasma and 200 µL D2O. 1H chemical shifts were referenced internally to the lactate resonance at 1.33 ppm, measured relative to the chemical shift of trimethylsilyl [2,2,3,3-2H4] propionate used as a reference. The solutions were transferred to 5-mm (o.d.) NMR tubes. Samples of liver tissue (
100 mg) were homogenized with a Polytron PT 2100 in 2 mL acetonitrile/H2O (50:50, v:v) containing 0.1% BHT in an ice-water bath. The homogenates were centrifuged at 5000 x g for 10 min at 4°C and the supernatants were removed and lyophilized. The resulting powders were reconstituted in 1 mL D2O and extracted with 2 mL chloroform/methanol (75/25, v:v) and finally centrifuged (5000 x g for 15 min at 4°C). The precipitates are referred to as the water-soluble liver extracts. The lipophilic supernatants were dried under a stream of nitrogen and reconstituted in 600 µL CDCl3. These are referred to as the chloroform/methanol liver extracts. The reconstituted solutions were transferred to NMR tubes.
NMR spectroscopic analyses.
All 1H NMR spectra were obtained on a Bruker DRX-600 Avance NMR spectrometer operating at 600.13 MHz for 1H resonance frequency using an inverse detection 5 mm 1H-13C-15N cryoprobe attached to a CryoPlatform (the preamplifier cooling unit). 1H experiments on urine samples were recorded using the Improved Watergate sequence (19) to suppress water resonance, accumulating 128 free induction decays into 32-K data points on a 12-ppm spectral width. The 1H NMR spectra of plasma samples were acquired at 300 K using the 1 dimensional Carr-Purcell-Meiboom-Gills spin echo pulse sequence (20), accumulating 256 free induction decays. The 1H NMR spectra of liver extracts were acquired at 300 K using a standard 1 dimensional single pulse (21). All NMR spectra were data-reduced using AMIX (version 3.1, Bruker Analytik) to integrate 0.01-ppm-wide regions for urine samples and 0.04-ppm-wide regions for plasma and liver samples corresponding to the region
10.0–0.5 ppm. The regions
6.5–4.5 ppm in the urine spectra,
5.1–4.5 ppm in the plasma spectra, and
5.0–4.7 ppm in the aqueous extracts were set to 0 integral value to remove the variability of water resonance suppression and cross-relaxation effects on the urea signal. The regions
7.5–6.8 ppm (chloroform) and
3.6–3.3 ppm (methanol) were removed from all chloroform/methanol liver extract spectra.
Measurement of liver betaine concentration by liquid chromatography-MS/MS. The betaine concentration in the aqueous liver extract was measured essentially as described by Holm et al. (22); water-soluble liver extracts were injected into a reverse-phased 150- x 2-mm C12 column (Jupiter Proteo 90A, Phenomenex) packed with 4-µm diameter particles; the mobile phase consisted of an isocratic eluent (98% water + 1% formic acid and 2% acetonitrile + 1% formic acid); the column effluent flow rate into the mass spectrometer was 200 µL/min and the injection interval (run time) was 5 min; detection was with an API 2000 Triple-quadrupole tandem mass spectrometer (Applied Biosystems) in the positive-ion mode equipped with electrospray interface, the collision energy was 37 eV, the declustering potential was 21 V, the capillary voltage was set at 5000 V, the ion source temperature was 550°C, and betaine was detected with the m/z 118–58 transition. Data were processed using Sciex software (v1.4.1, Applied Biosystems).
Data analysis. Values of energy and food intake, weight gain, feces weight, urine volume, relative cecum, liver and heart weights, fermentation, lipid and antioxidant status, and liver betaine concentration are all given as means ± SEM, and significance between the 2 groups at the end of the experiment (P < 0.05) was determined by Student's t test (STATVIEW software; version 5.0; SAS Institute). 1H NMR spectral data were analyzed by ANOVA and linear discriminant analyses (LDA) Dumas et al. (23). Briefly, ANOVA was used to select significant variables from the set of initial urinary variables as candidates for LDA. This factorial procedure is equivalent to a principal component analysis performed on the means (barycenters) of the groups for each date. The factorial map from this multidimensional analysis gives a hierarchy between the factors that may explain the total variance, in particular whether there are 1) significant trajectories revealed in urine fingerprints by changing diet, and 2) significant differences between urine fingerprints collected during PP and PA periods. The statistical calculations were made using S-Plus 2000 software (v2.0 Insightful Corporation) including MASS and Multidim libraries and SAS (v8.01, SAS Institute).
| Results |
|---|
|
|
|---|
) in the 2 groups (Table 1).
|
First, an ANOVA was performed on selected variables that significantly distinguished WGF and RF diets. Two hundred spectral regions of 0.01 ppm among the 750 of the entire spectra were selected and used for the LDA. The urinary profiles of rats fed WGF or RF were quite distinct (according to the first component LD1, which represents 30.2% of the between-group variance), as were the 2 urine sampling times (according to LD2, which represents 13.8% of the between-group variance) (Fig. 1). Changing from WGF to RF (d 14–15) or conversely produced a new metabolic balance within 48 h (Fig. 1). The urine samples collected in the morning and afternoon showed similar metabolic trajectories.
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Diurnal metabolic changes. Our metabonomic approach allowed us to compare urine collected from rats that were in PP (high activity, meal consumption during the night) and PA states (day). The excretions of citrate, 2-OG, lactate, and creatinine were increased in the PP state, whereas the excretion of DMA and tryptophan was higher in the PA period. Similar patterns of citrate, 2-OG, and creatinine urinary excretions have been described (28,29). These metabolites, together with lactate, reflect the greater activity of the rats during the night. DMA is a breakdown product of dietary choline, formed in the gut by the microbiota (30). Its higher excretion in the PA period may be explained by the time taken by the microbiota to metabolize it.
Metabolic changes in rats fed RF and WGF diets.
The metabolic profiles of rats fed WGF and RF diets differed, as reflected in their urine samples collected during PP and PA periods. The markers differentiating the 2 diets were similar for both types of urine samples. A new metabolic balance was reached within 48 h when switching from 1 diet to the other (Fig. 1). The consumption of the WGF diet resulted in increased urinary excretion of citrate, fumarate, tyrosine, tryptophan, phenylalanine, hippurate, and creatine. The high excretion of citrate could be caused by the higher intake of magnesium by rats on the WGF diet. A low magnesium status has been associated with hypocitraturia (31), and magnesium is
4 times more abundant in WGF than in RF (32). Hippurate is synthesized from benzoate and glycine in the kidney and liver and benzoate is also a breakdown product of several dietary polyphenols (33). Rats on the WGF diet may have excreted more hippurate in their urine because of the phenolic compounds in wheat bran (34).
Changes in metabolite concentrations were less pronounced in the plasma and liver than in the urine due to homeostatic control. The plasma of rats fed the WGF diet had a higher concentration of lysine, a difference likely explained by its higher concentration (x1.5) in WGF compared with RF (32). Some lipid signals were less intense (CH2-CO, CH2-OCOR, and CH2-CH2-CO) in the livers of rats fed the WGF diet, whereas total hepatic tryglycerides were unaffected as estimated by a conventional method.
The livers of rats fed the WGF also had more GSH, glucose, and betaine than the livers of RF-fed rats. The relatively high concentration of betaine in the liver might be due to the high betaine content of WGF. Wheat bran is a major dietary source of betaine (1.3 g/100 g) (35) and the concentration in white flour is, in comparison, very low (1.6 mg/100 g) (36). As bran accounts for 15–17% of whole-grain wheat, there would be
140 times more betaine in WGF than in RF. A higher betaine concentration in plasma and urine was previously observed in pigs fed a whole-grain rye diet (37). Betaine participates in the conversion of homocysteine to methionine. A dietary supplement of betaine stimulates the conversion of homocysteine to methionine in the liver of ethanol-treated rats (38), and methionine added to freshly isolated hepatocytes increases intracellular GSH (39,40). Betaine treatment also improves the antioxidant status of guinea pigs (41) and rats (42). The significantly higher betaine and GSH concentrations in the livers of these rat therefore suggests that WGF consumption has an antioxidant effect.
We conclude that our metabonomic approach shows that the consumption of WGF produces metabolic changes, some of which may protect the organism against oxidative stress. This high throughput approach may unravel subtle metabolic changes that measurements of classic markers of lipid and oxidative stress may fail to reveal. The metabolic effects of WGF help to explain the beneficial effects of whole-grain cereals on health. A particular attention should be paid to the high betaine concentration in whole-grain cereals which has been so far largely neglected when exploring the health benefit of whole-grain cereals.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
4 Abbreviations used: DMA, dimethylamine; 8-epi-PGF2
, 8-epi-prostaglandin F2
; FRAP, ferric-reducing ability of plasma; GSH, reduced glutathione; LDA, linear discriminant analysis; MDA, malondialdehydes; PA, postabsorptive; PP, postprandial; 2-OG, 2-oxoglutarate; RF, refined wheat flour; RF-WGF group, group of rats consuming the refined wheat flour-based diet first and then the whole-grain wheat flour-based diet; WGF, whole-grain wheat flour; WGF-RF group, group of rats consuming the whole-grain wheat flour-based diet first and then the refined wheat flour-based diet. ![]()
Manuscript received 7 August 2006. Initial review completed 29 August 2006. Revision accepted 3 January 2007.
| LITERATURE CITED |
|---|
|
|
|---|
1. Slavin JL, Jacobs D, Marquart L, Wiemer K. The role of whole grains in disease prevention. J Am Diet Assoc. 2001;101:780–5.[Medline]
2. Slavin J. Why whole grains are protective: biological mechanisms. Proc Nutr Soc. 2003;62:129–34.[Medline]
3. Bruce B, Spiller GA, Klevay LM, Gallagher SK. A diet high in whole and unrefined foods favorably alters lipids, antioxidant defenses, and colon function. J Am Coll Nutr. 2000;19:61–7.
4. Flight I, Clifton P. Cereal grains and legumes in the prevention of coronary heart disease and stroke: a review of the literature. Eur J Clin Nutr. 2006;60:1145–59.[Medline]
5. Thompson LU. Antioxidants and hormone-mediated health benefits of whole grains. Crit Rev Food Sci Nutr. 1994;34:473–97.[Medline]
6. Slavin JL, Martini MC, Jacobs DR, Marquart L. Plausible mechanisms for the protectiveness of whole grains. Am J Clin Nutr. 1999;70:S459–63.
7. Xia M, Ling WH, Ma J, Kitts DD, Zawistowski J. Supplementation of diets with the black rice pigment fraction attenuates atherosclerotic plaque formation in apolipoprotein e deficient mice. J Nutr. 2003;133:744–51.
8. Williams RE, Lenz EM, Lowden JS, Rantalainen M, Wilson ID. The metabonomics of aging and development in the rat: an investigation into the effect of age on the profile of endogenous metabolites in the urine of male rats using H-1 NMR and HPLC-TOF MS. Mol Biosyst. 2005;1:166–75.[Medline]
9. Gibney MJ, Walsh M, Brennan L, Roche HM, German B, van Ommen B. Metabolomics in human nutrition: opportunities and challenges. Am J Clin Nutr. 2005;82:497–503.
10. Wang Y, Tang H, Nicholson JK, Hylands PJ, Sampson J, Holmes E. A metabonomic strategy for the detection of the metabolic effects of chamomile (Matricaria recutita L.) ingestion. J Agric Food Chem. 2005;53:191–6.[Medline]
11. Solanky KS, Bailey NJ, Beckwith-Hall BM, Bingham S, Davis A, Holmes E, Nicholson JK, Cassidy A. Biofluid H-1 NMR-based metabonomic techniques in nutrition research metabolic effects of dietary isoflavones in humans. J Nutr Biochem. 2005;16:236–44.[Medline]
12. Solanky KS, Bailey NJC, Holmes E, Lindon JC, Davis AL, Mulder TPJ, Van Duynhoven JPM, Nicholson JK. NMR-based metabonomic studies on the biochemical effects of epicatechin in the rat. J Agric Food Chem. 2003;51:4139–45.[Medline]
13. Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993;123:1939–51.
14. Mazur A, Remesy C, Gueux E, Levrat MA, Demigne C. Effects of diets rich in fermentable carbohydrates on plasma lipoprotein levels and on lipoprotein catabolism in rats. J Nutr. 1990;120:1037–45.
15. Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP Assay. Anal Biochem. 1996;239:70–6.[Medline]
16. Lee HS, Shoeman DW, Csallany AS. Urinary response to in vivo lipid peroxidation induced by vitamin E deficiency. Lipids. 1992;27:124–8.[Medline]
17. Lyan B, Azais-Braesco V, Cardinault N, Tyssandier V, Borel P, Alexandre-Gouabau MC, Grolier P. Simple method for clinical determination of 13 carotenoids in human plasma using an isocratic high-performance liquid chromatographic method. J Chromatogr B Biomed Sci Appl. 2001;751:297–303.[Medline]
18. Tessier F, Birlouez-Aragon I, Tjani C, Guilland JC. Validation of a micromethod for determining oxidized and reduced vitamin C in plasma by HPLC-fluorescence. Int J Vitam Nutr Res. 1996;66:166–70.[Medline]
19. Liu ML, Mao XA, Ye CH, Huang H, Nicholson JK, Lindon JC. Improved WATERGATE pulse sequences for solvent suppression in NMR spectroscopy. J Magn Reson. 1998;132:125–9.
20. Nicholson JK, Foxall PJD, Spraul M, Farrant RD, Lindon JC. 750-Mhz H-1 and H-1-C-13 Nmr-spectroscopy of human blood-plasma. Anal Chem. 1995;67:793–811.[Medline]
21. Waters NJ, Holmes E, Waterfield CJ, Farrant RD, Nicholson JK. NMR and pattern recognition studies on liver extracts and intact livers from rats treated with alpha-naphthylisothiocyanate. Biochem Pharmacol. 2002;64:67–77.[Medline]
22. Holm PI, Ueland PM, Kvalheim G, Lien EA. Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin Chem. 2003;49:286–94.
23. Dumas ME, Canlet C, Andre F, Vercauteren J, Paris A. Metabonomic assessment of physiological disruptions using H-1-C-13 HMBC-NMR spectroscopy combined with pattern recognition procedures performed on filtered variables. Anal Chem. 2002;74:2261–73.[Medline]
24. Adam A, Lopez HW, Tressol JC, Leuillet M, Demigne C, Remesy C. Impact of whole wheat flour and its milling fractions on the cecal fermentations and the plasma and liver lipids in rats. J Agric Food Chem. 2002;50:6557–62.[Medline]
25. Lewis S, Bolton C, Heaton K. Lack of influence of intestinal transit on oxidative status in premenopausal women. Eur J Clin Nutr. 1996;50:565–8.[Medline]
26. Rezar V, Pajk T, Logar RM, Janezic VJ, Salobir K, Oresnik A, Salobir J. Wheat bran and oat bran effectively reduce oxidative stress induced by high-fat diets in pigs. Ann Nutr Metab. 2003;47:78–84.[Medline]
27. Adam A, Crespy V, Levrat-Verny MA, Leenhardt F, Leuillet M, Demigne C, Remesy C. The bioavailability of ferulic acid is governed primarily by the food matrix rather than its metabolism in intestine and liver in rats. J Nutr. 2002;132:1962–8.
28. Gavaghan CL, Wilson ID, Nicholson JK. Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA. FEBS Lett. 2002;530:191–6.[Medline]
29. Bollard ME, Holmes E, Lindon JC, Mitchell SC, Branstetter D, Zhang W, Nicholson JK. Investigations into biochemical changes due to diurnal variation and estrus cycle in female rats using high-resolution H-1 NMR spectroscopy of urine and pattern recognition. Anal Biochem. 2001;295:194–202.[Medline]
30. Lowis S, Eastwood MA, Brydon WG. The influence of creatinine, lecithin and choline feeding on aliphatic amine production and excretion in the rat. Br J Nutr. 1985;54:43–51.[Medline]
31. Reungjui S, Prasongwatana V, Premgamone A, Tosukhowong P, Jirakulsomchok S, Sriboonlue P. Magnesium status of patients with renal stones and its effect on urinary citrate excretion. BJU Int. 2002;90:635–9.[Medline]
32. Souci SW, Fachmann W, Kraut H. Food composition and nutritional tables. Stuttgart: Medpharm Scientific Publishers and CRC Press; 2000.
33. Clifford MN, Copeland EL, Bloxsidge JP, Mitchell LA. Hippuric acid as a major excretion product associated with black tea consumption. Xenobiotica. 2000;30:317–26.[Medline]
34. Phipps AN, Stewart J, Wright B, Wilson ID. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica. 1998;28:527–37.[Medline]
35. Zeisel SH, Mar MH, Howe JC, Holden JM. Concentrations of choline-containing compounds and betaine in common foods. J Nutr. 2003;133:1302–7. Erratum in J Nutr 2003;133:2918.
36. Sakamoto A, Nishimura Y, Ono H, Sakura N. Betaine and homocysteine concentrations in foods. Pediatr Int. 2002;44:409–13.[Medline]
37. Bertram HC, Bach Knudsen KE, Serena A, Malmendal A, Nielsen NC, Frette XC, Andersen HJ. NMR-based metabonomic studies reveal changes in the biochemical profile of plasma and urine from pigs fed high-fibre rye bread. Br J Nutr. 2006;95:955–62.[Medline]
38. Barak AJ, Beckenhauer HC, Mailliard ME, Kharbanda KK, Tuma DJ. Betaine lowers elevated S-adenosylhomocysteine levels in hepatocytes from ethanol-fed rats. J Nutr. 2003;133:2845–48.
39. Wang ST, Chen HW, Sheen LY, Lii CK. Methionine and cysteine affect glutathione level, glutathione-related enzyme activities and the expression of glutathione S-transferase isozymes in rat hepatocytes. J Nutr. 1997;127:2135–41.[Medline]
40. Aw TY, Ookhtens M, Kaplowitz N. Mechanism of inhibition of glutathione efflux by methionine from isolated rat hepatocytes. Am J Physiol. 1986;251:G354–61.[Medline]
41. Balkan J, Oztezcan S, Kucuk M, Cevikbas U, Kocak-Toker N, Uysal M. The effect of betaine treatment on triglyceride levels and oxidative stress in the liver of ethanol-treated guinea pigs. Exp Toxicol Pathol. 2004;55:505–9.[Medline]
42. Erman F, Balkan J, Cevikbas U, Kocak-Toker N, Uysal M. Betaine or taurine administration prevents fibrosis and lipid peroxidation induced by rat liver by ethanol plus carbon tetrachloride intoxication. Amino Acids. 2004;27:199–205.[Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||